Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis
Clinical trial NCT03816891 · COMPLETED
Trial details
- NCT number
- NCT03816891
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-11
- Primary completion
- 2022-12-28
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.